Precigen (PGEN) Liabilities and Shareholders Equity: 2012-2024
Historic Liabilities and Shareholders Equity for Precigen (PGEN) over the last 13 years, with Dec 2024 value amounting to $145.3 million.
- Precigen's Liabilities and Shareholders Equity rose 105.17% to $171.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $547.2 million, marking a year-over-year increase of 23.66%. This contributed to the annual value of $145.3 million for FY2024, which is 3.82% down from last year.
- Latest data reveals that Precigen reported Liabilities and Shareholders Equity of $145.3 million as of FY2024, which was down 3.82% from $151.0 million recorded in FY2023.
- Precigen's Liabilities and Shareholders Equity's 5-year high stood at $359.9 million during FY2021, with a 5-year trough of $145.3 million in FY2024.
- In the last 3 years, Precigen's Liabilities and Shareholders Equity had a median value of $151.0 million in 2023 and averaged $170.8 million.
- In the last 5 years, Precigen's Liabilities and Shareholders Equity grew by 14.39% in 2021 and then plummeted by 39.98% in 2022.
- Over the past 5 years, Precigen's Liabilities and Shareholders Equity (Yearly) stood at $314.6 million in 2020, then climbed by 14.39% to $359.9 million in 2021, then plummeted by 39.98% to $216.0 million in 2022, then plummeted by 30.07% to $151.0 million in 2023, then declined by 3.82% to $145.3 million in 2024.